Now Reading: Marico buys 24% more in PLIX parent for ₹1,012 crore
-
01
Marico buys 24% more in PLIX parent for ₹1,012 crore
Marico has raised its stake in Satiya Nutraceuticals, owner of the health brand PLIX, to 84.09% by buying an additional 24.09% for ₹1,012.03 crore, the company said on 5 October in a regulatory filing. The total consideration for the 84.09% holding is ₹1,392.07 crore. The remaining 14.09% stake held by the founders is to be bought in July 2027, with a base consideration of up to ₹592 crore plus milestone-linked payments.
Separately, Marico said its India business delivered double-digit volume growth in the quarter ended 30 September, with Parachute Coconut Oil posting early-teens growth. Saffola Oil recorded mid-single-digit price-led growth but volumes declined as the company prioritised profitability. The international business also grew in the teens. Marico expects consolidated revenue growth in double digits and operating profit growth in the mid-twenties, and said it is likely to surpass its near-term guidance.
Indian Opinion Analysis
Both CNBC-TV18 and The Economic Times present the acquisition and quarterly update as straight factual coverage with no discernible slant, using near-identical figures, timelines and commentary from Marico's exchange filing. Neither outlet questions the deal's pricing, the related-party nature of the transaction, or the strategic rationale. The coverage is uniform wire-copy style reporting. The key figure to track is whether Marico completes the remaining 14.09% acquisition by July 2027 at the stated base consideration of ₹592 crore, and whether the milestone-linked payments alter the final outlay.
Coverage: 2 sources, 2 neutral
Sources (2): cnbctv18.com (neutral report), economictimes.indiatimes.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.
